Health care delivery is often inefficient and expensive, but a new clinic in Camden, N.J., may change that. The clinic, which was to open in late April, is located in Northgate II, a public house apartment building where more than 300 low-income residents live. The location was chosen after research data showed that many residents [...]
The U.S. Food and Drug Administration today approved the use of Menactra in children as young as 9 months for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135. Menactra already is approved for use in people ages 2 through 55 years. Meningococcal disease is a life-threatening illness caused by [...]
by: Daniel J. DeNoon April 20, 2011 — The FDA has approved Roche's new test for human papillomavirus (HPV), the first one-pass test to specifically identify the two HPV strains that cause 70% of cervical cancers. The sexually transmitted human papillomavirus causes nearly all cervical cancers. Current HPV tests can detect the presence or absence [...]
Source: United States Food and Drug Administration The Food and Drug Administration (FDA) has announced a new risk reduction program—the Risk Evaluation and Mitigation Strategy—for all extended-release and long-acting opioid medications. Opioids are synthetic versions of opium and are used to treat moderate and severe pain. FDA experts say extended-release and long-acting opioids—including the commonly [...]
By The Jere Beasley Report, April 2011 Each year, millions of people in the United States sustain traumatic brain injuries (TBI) from falls, motor vehicle traffic crashes, collisions with moving or stationary objects, and assaults. The Centers for Disease Control and Prevention (CDC) estimates TBI will affect 1.7 million people, resulting in 1.365 million emergency [...]
Source: Journal of Clinical Oncology, March 21, 2011 A 10 year follow-up of women aged 50 and over with early breast cancer whose chemotherapy included Tamoxifen has been published in the Journal of Clinical Oncology. The study by researchers at Cancer Research UK touts the benefits of 5 years of Tamoxifen therapy. Tamoxifen or NOLVADEX® [...]
Source: New York Times National Ed., 3/6/2011; US Food & Drug Administration We previously reported on radiation errors with CT brain perfusion scans when they were widely reported in the summer of 2009 at Cedars-Sinai. Following reports at several other hospitals, the Food and Drug Administration conducted an investigation into why patients tested with this [...]
Sources: BBC Health News; Journal Neurology; Fox Foundation Parkinson's Disease is a debilitating one, affecting 1 in every 500 people over the age of 50. It is linked with a shortage of the brain chemical dopamine and follows the death of important nerves cells. Parkinson's Disease is both chronic (persists over a long period of [...]
Source: NYT Sunday Opinion, 2/27/2011, Abraham Verghese Stanford University School of Medicine's Professor and author, Abraham Verghese has made timely observations as our society becomes ever more dependent upon technology and artificial intelligence, particularly as it relates to modern medicine. "When I was an intern some 30 years ago, about three million CT scans were [...]
Source: Journal Pediatrics, 2011. A recent study by Danish researchers of the Department of Epidemiology, School of Public Health, University of Aarhus, concludes that a low Apgar score is associated with an increased risk of ADHD in childhood. What does it all mean? The Apgar score was devised in 1952 by Dr. Virginia Apgar (an [...]